NORD to Collaborate with FDA on Pilot Patient Engagement Activity
Listening Sessions to Enable Sharing Rare Disease Experiences with FDA Review Divisions Washington, D.C., February 28, 2018—The National Organization for Rare Disorders (NORD), the leading independent nonprofit organization representing the …
Continue reading “NORD to Collaborate with FDA on Pilot Patient Engagement Activity”
Read more